These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 10695642

  • 1. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.
    Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E.
    J Clin Psychiatry; 2000 Jan; 61(1):26-9. PubMed ID: 10695642
    [Abstract] [Full Text] [Related]

  • 2. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 3. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R, Chen J, Entsuah AR, Schatzberg AF.
    J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Stahl SM, Entsuah R, Rudolph RL.
    Biol Psychiatry; 2002 Dec 15; 52(12):1166-74. PubMed ID: 12488062
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH, Salinas E.
    J Clin Psychiatry; 2001 Jul 15; 62(7):523-9. PubMed ID: 11488362
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Once- versus twice-daily venlafaxine therapy in major depression: a randomized, double-blind study.
    Amsterdam JD, Hooper MB, Amchin J.
    J Clin Psychiatry; 1998 May 15; 59(5):236-40. PubMed ID: 9632034
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Problems with ensuring a double blind.
    Kumar S, Oakley-Browne M.
    J Clin Psychiatry; 2001 Apr 15; 62(4):295-6. PubMed ID: 11379846
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
    Silverstone PH, Entsuah R, Hackett D.
    Int Clin Psychopharmacol; 2002 Nov 15; 17(6):273-80. PubMed ID: 12409680
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
    Wijkstra J, Burger H, van den Broek WW, Birkenhäger TK, Janzing JG, Boks MP, Bruijn JA, van der Loos ML, Breteler LM, Ramaekers GM, Verkes RJ, Nolen WA.
    Acta Psychiatr Scand; 2010 Mar 15; 121(3):190-200. PubMed ID: 19694628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.
    Oslin DW, Ten Have TR, Streim JE, Datto CJ, Weintraub D, DiFilippo S, Katz IR.
    J Clin Psychiatry; 2003 Aug 15; 64(8):875-82. PubMed ID: 12927001
    [Abstract] [Full Text] [Related]

  • 17. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
    Khan A, Upton GV, Rudolph RL, Entsuah R, Leventer SM.
    J Clin Psychopharmacol; 1998 Feb 15; 18(1):19-25. PubMed ID: 9472838
    [Abstract] [Full Text] [Related]

  • 18. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.
    Encephale; 2009 Dec 15; 35(6):595-604. PubMed ID: 20004291
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.
    Guelfi JD, White C, Hackett D, Guichoux JY, Magni G.
    J Clin Psychiatry; 1995 Oct 15; 56(10):450-8. PubMed ID: 7559370
    [Abstract] [Full Text] [Related]

  • 20. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
    Kroenke K, Messina N, Benattia I, Graepel J, Musgnung J.
    J Clin Psychiatry; 2006 Jan 15; 67(1):72-80. PubMed ID: 16426091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.